Published in Curr Opin Immunol on July 18, 2011
Natural Killer Cells and Bortezomib to Treat Cancer | NCT00720785
Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice. Br J Cancer (2013) 1.15
Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia. Clin Exp Immunol (2016) 0.79
Gut-targeted immunonutrition boosting natural killer cell activity using Saccharomyces boulardii lysates in immuno-compromised healthy elderly subjects. Rejuvenation Res (2014) 0.75
Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms. Oncoimmunology (2017) 0.75
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol (2009) 9.41
Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 8.95
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol (1999) 7.60
IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91
Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest (2007) 6.31
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity (2008) 5.35
The aging immune system: primer and prospectus. Science (1996) 4.86
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res (2002) 2.86
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol (2001) 2.71
NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol (2001) 2.69
Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol (2007) 2.04
Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 2.03
The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol (2005) 2.01
Aging and innate immune cells. J Leukoc Biol (2004) 1.94
Innate immunity and aging. Exp Gerontol (2008) 1.73
Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol (2006) 1.69
Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine (2006) 1.57
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol (2008) 1.57
Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother (2002) 1.47
Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev (1992) 1.46
Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol (2000) 1.43
High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res (2009) 1.39
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol (2004) 1.32
Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer. Cancer Res (2007) 1.26
Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol (2009) 1.22
Liver NKT cells: an account of heterogeneity. Trends Immunol (2003) 1.16
NK and NKT cell functions in immunosenescence. Aging Cell (2004) 1.16
Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev (2007) 1.14
Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol (1998) 1.11
Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells. J Immunol (2001) 1.10
Replicative senescence of CD8 T cells: effect on human ageing. Exp Gerontol (2004) 1.09
Aged mice develop protective antitumor immune responses with appropriate costimulation. J Immunol (2004) 1.09
Natural killer cells in the late decades of human life. Clin Immunol Immunopathol (1997) 1.07
Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol (2005) 1.04
Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >/=90 y. Am J Clin Nutr (2000) 1.00
Effect of aging on epidermal dendritic cell populations in C57BL/6J mice. J Invest Dermatol (1990) 0.99
Reduced IFN-gamma production in elderly people following in vitro stimulation with influenza vaccine and endotoxin. Mech Ageing Dev (2000) 0.98
Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells. Oncol Res (2000) 0.97
Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status. J Natl Cancer Inst Monogr (2001) 0.97
Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer. Br J Cancer (2009) 0.97
Split-virus influenza vaccines: do they provide adequate immunity in the elderly? J Gerontol (1994) 0.96
Mechanisms of murine dendritic cell antitumor dysfunction in aging. Cancer Immunol Immunother (2008) 0.96
Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. Gene Ther (2000) 0.95
Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol (1998) 0.91
Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine (2003) 0.90
CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. J Leukoc Biol (2002) 0.87
Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells. Clin Exp Metastasis (2000) 0.86
The importance of the age factor in cancer vaccination at older age. Cancer Immunol Immunother (2009) 0.86
A new mechanism for blocking myeloid-derived suppressor cells by CpG. Clin Cancer Res (2011) 0.84
Recall immune memory: a new tool for generating late onset autoimmune myasthenia gravis. Mech Ageing Dev (2003) 0.81
In vitro and in vivo activation of CD4+ lymphocytes by autologous tumor cells. Int J Cancer (1990) 0.80